Emerging roles of pseudokinases

Trends in Cell Biology

Volumn 16, Issue 9, 2006, Pages 443-452

  Boudeau, Jérôme ^a   Miranda Saavedra, Diego ^a   Barton, Geoffrey J ^a   Alessi, Dario R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR B6; INTEGRIN LINKED KINASE; JANUS KINASE 2; PROTEIN; PROTEIN CASK; PROTEIN GCN2; PROTEIN KINASE; PROTEIN KINASE LKB1; PROTEIN STRAD; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; JANUS KINASE 2; MICE; MUTATION; MYELOPROLIFERATIVE DISORDERS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 33747886526     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2006.07.003     Document Type: Review

References (71)

1. Manning G., et al. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
2. Caenepeel S., et al. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11707-11712
3. Plowman G.D., et al. The protein kinases of Caenorhabditis elegans: a model for signal transduction in multicellular organisms. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13603-13610
4. Goldberg J.M., et al. The dictyostelium kinome-analysis of the protein kinases from a simple model organism. PLoS Genet. 2 (2006) e38
5. Hunter T., and Plowman G.D. The protein kinases of budding yeast: six score and more. Trends Biochem. Sci. 22 (1997) 18-22
6. Manning G., et al. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27 (2002) 514-520
7. Xu B., et al. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 275 (2000) 16795-16801
8. Min X., et al. Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure 12 (2004) 1303-1311
9. Abe Y., et al. Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes. J. Biol. Chem. 276 (2001) 44003-44011
10. Higgins J.M. Haspin-like proteins: a new family of evolutionarily conserved putative eukaryotic protein kinases. Protein Sci. 10 (2001) 1677-1684
11. Tanaka H., et al. Identification and characterization of a haploid germ cell-specific nuclear protein kinase (Haspin) in spermatid nuclei and its effects on somatic cells. J. Biol. Chem. 274 (1999) 17049-17057
12. Tanaka H., et al. Cloning and characterization of human haspin gene encoding haploid germ cell-specific nuclear protein kinase. Mol. Hum. Reprod. 7 (2001) 211-218
13. Mayans O., et al. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 395 (1998) 863-869
14. Scheeff E.D., and Bourne P.E. Structural evolution of the protein kinase-like superfamily. PLoS Comput. Biol. 1 (2005) e49
15. Katso R.M., et al. Functional analysis of H-Ryk, an atypical member of the receptor tyrosine kinase family. Mol. Cell. Biol. 19 (1999) 6427-6440
16. Yoshikawa S., et al. The derailed guidance receptor does not require kinase activity in vivo. J. Neurosci. 21 (2001) RC119
17. Prigent S.A., and Gullick W.J. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 13 (1994) 2831-2841
18. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
19. van der Geer P., et al. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10 (1994) 251-337
20. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2 (2001) 127-137
21. Hynes N.E., and Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5 (2005) 341-354
22. Holbro T., et al. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8933-8938
23. Berger M.B., et al. ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface. FEBS Lett. 569 (2004) 332-336
24. Zhang X., et al. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125 (2006) 1137-1149
25. Gerlai R. Eph receptors and neural plasticity. Nat. Rev. Neurosci. 2 (2001) 205-209
26. Gurniak C.B., and Berg L.J. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. Oncogene 13 (1996) 777-786
27. Luo H., et al. EphB6-null mutation results in compromised T cell function. J. Clin. Invest. 114 (2004) 1762-1773
28. Freywald A., et al. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J. Biol. Chem. 277 (2002) 3823-3828
29. Easty D.J., et al. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int. J. Cancer 71 (1997) 1061-1065
30. Shaheen R.M., et al. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br. J. Cancer 85 (2001) 584-589
31. Lu X., et al. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 430 (2004) 93-98
32. Winberg M.L., et al. The transmembrane protein Off-track associates with Plexins and functions downstream of Semaphorin signaling during axon guidance. Neuron 32 (2001) 53-62
33. Kroiher M., et al. Deceiving appearances: signaling by "dead" and "fractured" receptor protein-tyrosine kinases. Bioessays 23 (2001) 69-76
34. Dan I., et al. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11 (2001) 220-230
35. Baas A.F., et al. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 22 (2003) 3062-3072
36. Alessi D.R., et al. LKB1-dependent signaling pathways. Annu. Rev. Biochem. 75 (2006) 137-163
37. Boudeau J., et al. Analysis of the LKB1-STRAD-MO25 complex. J. Cell Sci. 117 (2004) 6365-6375
38. Boudeau J., et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 22 (2003) 5102-5114
39. Luo H., et al. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol. 17 (1997) 1562-1571
40. Saharinen P., et al. Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. Mol. Biol. Cell 14 (2003) 1448-1459
41. Yeh T.C., et al. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8991-8996
42. Lindauer K., et al. Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Eng. 14 (2001) 27-37
43. Shannon K., and Van Etten R.A. JAKing up hematopoietic proliferation. Cancer Cell 7 (2005) 291-293
44. Staerk J., et al. JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J. Biol. Chem. 280 (2005) 41893-41899
45. Qiu H., et al. Dimerization by translation initiation factor 2 kinase GCN2 is mediated by interactions in the C-terminal ribosome-binding region and the protein kinase domain. Mol. Cell. Biol. 18 (1998) 2697-2711
46. Wek R.C., et al. Identification of positive-acting domains in GCN2 protein kinase required for translational activation of GCN4 expression. Mol. Cell. Biol. 10 (1990) 2820-2831
47. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6 (2005) 827-837
48. Morrison D.K. KSR: a MAPK scaffold of the Ras pathway?. J. Cell Sci. 114 (2001) 1609-1612
49. Templeton G.W., and Moorhead G.B. The phosphoinositide-3-OH-kinase-related kinases of Arabidopsis thaliana. EMBO Rep. 6 (2005) 723-728
50. Herceg Z., and Wang Z.Q. Rendez-vous at mitosis: TRRAPed in the chromatin. Cell Cycle 4 (2005) 383-387
51. Murr R., et al. Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat. Cell Biol. 8 (2006) 91-99
52. Herceg Z., et al. Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat. Genet. 29 (2001) 206-211
53. Rorth P., et al. The level of C/EBP protein is critical for cell migration during Drosophila oogenesis and is tightly controlled by regulated degradation. Mol. Cell 6 (2000) 23-30
54. Bowers A.J., et al. SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene 22 (2003) 2823-2835
55. Ohoka N., et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 24 (2005) 1243-1255
56. Ord D., and Ord T. Characterization of human NIPK (TRB3, SKIP3) gene activation in stressful conditions. Biochem. Biophys. Res. Commun. 330 (2005) 210-218
57. Qi L., et al. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 312 (2006) 1763-1766
58. Du K., et al. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300 (2003) 1574-1577
59. Koo S.H., et al. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10 (2004) 530-534
60. Iynedjian P.B. Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes. Biochem. J. 386 (2005) 113-118
61. Delcommenne M., et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11211-11216
62. Sarbassov D.D., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14 (2004) 1296-1302
63. Sakai T., et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev. 17 (2003) 926-940
64. Grashoff C., et al. Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep. 4 (2003) 432-438
65. Legate K.R., et al. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell Biol. 7 (2006) 20-31
66. Li Y., et al. Structural basis for nucleotide-dependent regulation of membrane-associated guanylate kinase-like domains. J. Biol. Chem. 277 (2002) 4159-4165
67. Tabuchi K., et al. CASK participates in alternative tripartite complexes in which Mint 1 competes for binding with caskin 1, a novel CASK-binding protein. J. Neurosci. 22 (2002) 4264-4273
68. Zordan M.A., et al. Drosophila CAKI/CMG protein, a homolog of human CASK, is essential for regulation of neurotransmitter vesicle release. J. Neurophysiol. 94 (2005) 1074-1083
69. Wang T.F., et al. Identification of Tbr-1/CASK complex target genes in neurons. J. Neurochem. 91 (2004) 1483-1492
70. Mulder N.J., et al. InterPro, progress and status in 2005. Nucleic Acids Res. 33 (2005) D201-D205
71. Abril J.F., and Guigo R. gff2ps: visualizing genomic annotations. Bioinformatics 16 (2000) 743-744